| Net Cash Provided by (Used in) Operating Activities |
-238K |
USD |
-215% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
239K |
USD |
+498% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
500M |
shares |
|
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
13.9M |
shares |
|
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-593 |
USD |
-51.7% |
Q1 2023 |
Q1 2023 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
7.85K |
USD |
+391% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
17.5M |
USD |
+7.35% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
17.5M |
USD |
+7.35% |
Q4 2024 |
FY 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
195K |
USD |
-36.5% |
Q1 2023 |
Q1 2023 |
| Deferred Tax Assets, Operating Loss Carryforwards |
7.48M |
USD |
+3.25% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
10M |
shares |
|
Q4 2023 |
FY 2024 |
| Preferred Stock, Shares Authorized |
50M |
shares |
0% |
Q4 2023 |
FY 2024 |
| Additional Paid in Capital |
104M |
USD |
+17.7% |
Q1 2024 |
Q1 2024 |
| Preferred Stock, Shares Outstanding |
10M |
shares |
0% |
Q4 2023 |
FY 2024 |
| Interest Expense |
863K |
USD |
+18.4% |
Q3 2023 |
Q3 2023 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q4 2023 |
FY 2024 |